Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Common Stock | Options Exercise | $9.55K | +5K | +39.89% | $1.91* | 17.5K | Jul 19, 2021 | Direct | F1 |
transaction | CRNX | Common Stock | Sale | -$97.5K | -5K | -28.51% | $19.50 | 12.5K | Jul 19, 2021 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRNX | Non-qualified stock option (Right to Buy) | Options Exercise | $0 | -5K | -13.48% | $0.00 | 32.1K | Jul 19, 2021 | Common stock | 5K | $1.91 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. |
F2 | Stock option granted March 17, 2018 with one-third vesting on the first anniversary of the grant date and the remainder vesting in a series of twenty-four (24) successive equal monthly installments thereafter. |
F3 | The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $19.50. The range of sales prices on the transaction date was $19.50 to $19.52 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |